Market

China accounted for 67.56 per cent of total imports of bulk drugs and drug intermediates in 2018-19 at USD 2,405.42 million

The company had posted a net profit of Rs 510.7 crore for the corresponding period of the previous fiscal, Cadila Healthcare said…

Growth across key business drove overall revenue growth of 9 per cent on a year on year basis with adjusted EBITDA at 18.5 per…

The launch strengthens GSK’s pain relief portfolio in India making it one of the formidable players in the non-prescription space.…

The international technology group managed to increase its sales by 5.1 per cent to around EUR 2.2 billion. The operating result…

The company will develop and launch a portfolio of vitamins and nutritional supplements in gummy format, without the use of…

Triferic is an innovative anaemia therapy for the patients who are undergoing haemodialysis and offers a unique treatment option

Under the deal, Pfizer will get $75 million upfront and will be eligible for $635 million in potential milestone payments

Novartis, Merck and Allergan Plc were among companies that raised US prices on more than 100 prescription medicines on Friday,…

More price increases are expected to be announced later this week, which could affect the median and range